Literature DB >> 6321633

A new channel-forming antibiotic from Streptomyces coelicolor A3(2) which requires calcium for its activity.

J H Lakey, E J Lea, B A Rudd, H M Wright, D A Hopwood.   

Abstract

A recently discovered antibiotic (CDA; calcium-dependent antibiotic) of Streptomyces coelicolor A3(2) was found to be effective against a wide range of Gram-positive bacteria only in the presence of calcium ions. Producer and non-producer strains were identified and several media tested for their ability to support antibiotic production. The action of calcium was not simulated by any of the other cations tested. The antibiotic was found to induce discrete conductance fluctuations in planar lipid bilayer consistent with a channel-forming action. The electrical potential difference caused by a concentration difference of various salts across the CDA-containing bilayer, showed the channel to be cation-selective but of a size that discriminated against tetramethyl ammonium and choline ions. The data indicate that the antibiotic activity of CDA is due to its action as a calcium-dependent ionophore.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6321633     DOI: 10.1099/00221287-129-12-3565

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  30 in total

1.  Characterization of the pathway-specific positive transcriptional regulator for actinorhodin biosynthesis in Streptomyces coelicolor A3(2) as a DNA-binding protein.

Authors:  P Arias; M A Fernández-Moreno; F Malpartida
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

2.  Crystal structures of the first condensation domain of CDA synthetase suggest conformational changes during the synthetic cycle of nonribosomal peptide synthetases.

Authors:  Kristjan Bloudoff; Dmitry Rodionov; T Martin Schmeing
Journal:  J Mol Biol       Date:  2013-06-10       Impact factor: 5.469

Review 3.  Actinomycetes biosynthetic potential: how to bridge in silico and in vivo?

Authors:  Yuriy Rebets; Elke Brötz; Bogdan Tokovenko; Andriy Luzhetskyy
Journal:  J Ind Microbiol Biotechnol       Date:  2013-10-15       Impact factor: 3.346

4.  Mutations in a new Streptomyces coelicolor locus which globally block antibiotic biosynthesis but not sporulation.

Authors:  T Adamidis; P Riggle; W Champness
Journal:  J Bacteriol       Date:  1990-06       Impact factor: 3.490

5.  The lipopeptide antibiotic A54145 biosynthetic gene cluster from Streptomyces fradiae.

Authors:  Vivian Miao; Renee Brost; Joanne Chapple; Kevin She; Marie-François Coëffet-Le Gal; Richard H Baltz
Journal:  J Ind Microbiol Biotechnol       Date:  2005-10-06       Impact factor: 3.346

6.  Phage-mediated cloning of bldA, a region involved in Streptomyces coelicolor morphological development, and its analysis by genetic complementation.

Authors:  J M Piret; K F Chater
Journal:  J Bacteriol       Date:  1985-09       Impact factor: 3.490

Review 7.  Daptomycin, a bacterial lipopeptide synthesized by a nonribosomal machinery.

Authors:  Lars Robbel; Mohamed A Marahiel
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

8.  Nucleotide sequence of afsB, a pleiotropic gene involved in secondary metabolism in Streptomyces coelicolor A3(2) and "Streptomyces lividans".

Authors:  S Horinouchi; H Suzuki; T Beppu
Journal:  J Bacteriol       Date:  1986-10       Impact factor: 3.490

9.  In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens.

Authors:  Peter J Petersen; Patricia A Bradford; William J Weiss; Timothy M Murphy; P E Sum; Steven J Projan
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

10.  Phosphoenolpyruvate carboxylase from Streptomyces coelicolor A3(2): purification of the enzyme, cloning of the ppc gene and over-expression of the protein in a streptomycete.

Authors:  H Bramwell; H G Nimmo; I S Hunter; J R Coggins
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.